https://www.selleckchem.com/pr....oducts/vps34-inhibit
3 g/g. Median time to CR was 12.4 months. At 1, 3, and 6 months after initiating RCP therapy, 64%, 86%, and 100% of patients who were anti-PLA2R seropositive at baseline (n = 29) achieved immunologic remission (defined by an anti-PLA2R titer 14 RU/mL), respectively. After 1 year, UPCR fell from a median 8.4 (IQR, 5.0 - 10.7) to 0.3 (0.2 - 0.8) g/g (P 0.001). Relapse occurred in 10% of patients at 2 years after B cell reconstitution. Over a combined follow-up time of 228 patient-years, 18 SAEs occurred. One death occu
Like
Comment
Share
